Law Offices of Todd M. Garber Announces Lead Plaintiff Deadline In The Class Action Lawsuit Against AVEO Pharmaceuticals, Inc. Business Wire LOS ANGELES -- June 24, 2013 The Law Offices of Todd M. Garber announces that investors of AVEO Pharmaceuticals, Inc. (“AVEO” or the “Company”) (NASDAQ: AVEO) have until July 8, 2013 to move for lead plaintiff status in the shareholder lawsuit filed in the United States District Court for the District of Massachusetts. The lawsuit was filed on behalf of a class (the “Class”) comprising all purchasers of AVEO securities between January 3, 2012 and May 1, 2013 (the “Class Period”). AVEO engages in discovering, developing, and commercializing targeted cancer therapies. The Complaint alleges that defendants issued materially false and misleading statements throughout the Class Period regarding the Phase III trial design and results for the Company’s drug Tivopath, or tivozanib, for the treatment of advanced kidney cancer. Specifically, defendants misrepresented or failed to disclose: (1) that the FDA had recommended that the Company conduct an additional Phase III trial due to adverse trends in the Company’s first Phase III trial; (2) the 25% higher rate of death associated with tivozanib therapy compared to the control drug, sorafenib; (3) that almost 90% of the patients studied in TIVO-1 were enrolled from sites in Central and Eastern Europe with inconsistent treatment patterns from those in the U.S.; and (4) as a result of the foregoing, the Company’s statements were materially false and misleading at all relevant times. If you are a member of the above-described Class, you may move the Court no later than July 8, 2013 to serve as lead plaintiff; however, you must meet certain legal requirements. To be a member of the Class you need not take any action at this time. You may retain counsel of your choice or take no action and remain an absent Class member. If you purchased AVEO shares prior to the Class Period, or have any questions concerning this Notice or your rights or interests with respect to these matters, please contact Todd M. Garber, Esquire, of the Law Offices of Todd M. Garber, by telephone at 213-700-7262 or by email to firstname.lastname@example.org. This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules. Contact: Law Offices of Todd M. Garber Todd M. Garber, Attorney at Law Los Angeles, California 213-700-7262 email@example.com
Law Offices of Todd M. Garber Announces Lead Plaintiff Deadline In The Class Action Lawsuit Against AVEO Pharmaceuticals, Inc.
Press spacebar to pause and continue. Press esc to stop.